1. Home
  2. ALF vs HUMA Comparison

ALF vs HUMA Comparison

Compare ALF & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALF
  • HUMA
  • Stock Information
  • Founded
  • ALF 2024
  • HUMA 2004
  • Country
  • ALF United States
  • HUMA United States
  • Employees
  • ALF N/A
  • HUMA N/A
  • Industry
  • ALF
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALF
  • HUMA Health Care
  • Exchange
  • ALF NYSE
  • HUMA Nasdaq
  • Market Cap
  • ALF 379.1M
  • HUMA 356.8M
  • IPO Year
  • ALF 2024
  • HUMA N/A
  • Fundamental
  • Price
  • ALF $10.51
  • HUMA $2.28
  • Analyst Decision
  • ALF
  • HUMA Strong Buy
  • Analyst Count
  • ALF 0
  • HUMA 7
  • Target Price
  • ALF N/A
  • HUMA $13.00
  • AVG Volume (30 Days)
  • ALF 74.9K
  • HUMA 4.4M
  • Earning Date
  • ALF 01-01-0001
  • HUMA 08-12-2025
  • Dividend Yield
  • ALF N/A
  • HUMA N/A
  • EPS Growth
  • ALF N/A
  • HUMA N/A
  • EPS
  • ALF 0.37
  • HUMA N/A
  • Revenue
  • ALF N/A
  • HUMA $517,000.00
  • Revenue This Year
  • ALF N/A
  • HUMA N/A
  • Revenue Next Year
  • ALF N/A
  • HUMA $936.09
  • P/E Ratio
  • ALF $28.28
  • HUMA N/A
  • Revenue Growth
  • ALF N/A
  • HUMA N/A
  • 52 Week Low
  • ALF $9.96
  • HUMA $1.15
  • 52 Week High
  • ALF $10.64
  • HUMA $9.68
  • Technical
  • Relative Strength Index (RSI)
  • ALF N/A
  • HUMA 45.75
  • Support Level
  • ALF N/A
  • HUMA $2.32
  • Resistance Level
  • ALF N/A
  • HUMA $2.54
  • Average True Range (ATR)
  • ALF 0.00
  • HUMA 0.19
  • MACD
  • ALF 0.00
  • HUMA -0.02
  • Stochastic Oscillator
  • ALF 0.00
  • HUMA 13.58

About ALF CENTURION ACQUISITION CORP

Centurion Acquisition Corp is a blank check company.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: